To implement the relevant provisions of the Drug Administration Law and the Vaccine Administration Law, strengthen the management of records and data of drug R&D, manufacture, distribution and use, and ensure that the relevant information is true, accurate, complete and traceable, NMPA has organized to formulate the Requirements forthe Management of Drug Records and Data (Interim), which has been issued on June 24, 2020 and shall take effect as from December 1, 2020.